Chemical similarity and biological activities

"Similar molecules exert similar biological activities". Since long, medicinal chemists use this concept to modify the structures of biologically active compounds. Bioisosteric replacements of atoms and groups pave the way from various lead structures to therapeutically useful enzyme inhibitors, receptor agonists and antagonists, and other active principles. However, similarity and diversity of chemical structures cannot be defined in an objective manner. Several surprising structure-activity relationships demonstrate that chemically similar compounds may have significantly different biological actions and activities. Some protein ligands exert unexpected new binding modes, after only minor chemical modification. Of course, even optical enantiomers most often have different biological activities.

[1]  Hugo Kubinyi,et al.  Similarity and Dissimilarity: A Medicinal Chemist’s View , 2002 .

[2]  Pandi Veerapandian,et al.  Structure-based drug design , 1997 .

[3]  Manfred E. Wolff,et al.  Burger's Medicinal chemistry , 1980 .

[4]  Aalt Bast,et al.  Comprehensive medicinal chemistry , 1991 .

[5]  G A Petsko,et al.  Chemistry and biology. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P. Timmermans Stereochemistry and Biological Activity of Drugs , 1983 .

[7]  H. Kubinyi,et al.  3D QSAR in drug design. , 2002 .

[8]  Klaus Gubernator,et al.  Structure-Based Ligand Design , 1995 .

[9]  A Burger,et al.  Isosterism and bioisosterism in drug design. , 1991, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[10]  C L Verlinde,et al.  Structure-based drug design: progress, results and challenges. , 1994, Structure.

[11]  E. LaVoie,et al.  Bioisosterism: A Rational Approach in Drug Design. , 1996, Chemical reviews.

[12]  Corwin Hansch,et al.  Comprehensive medicinal chemistry : the rational design, mechanistic study & therapeutic application of chemical compounds , 1990 .

[13]  C. Brown Chirality in drug design and synthesis , 1990 .